IGFBP-3: Expression and prognostic significance in epithelial ovarian cancer;IGFBP-3: Espressione e significato prognostico nel carcinoma ovarico epiteliale

Minerva Ginecologica

Volumn 54, Issue 1, 2002, Pages 15-24

  Katsaros, D ^a   Yu, H ^b   Piccinno, R ^a   Puopolo, M ^a   Rigault De La Longrais, I A ^a   Fracchioli, S ^a   Massobrio, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Insuline like growth factor binding protein 3; Insuline like growth factor I; Ovarian neoplasms, diagnosis

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CARCINOMA; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 0036479393     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1998. Ca Cancer J Clin 1998;48:6-29.
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1998. Ca Cancer J Clin 1998;48:6-29.
3. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1994, National Cancer Institute. NIH Pub No. 97-2789. Bethesda, MD, 1997.
4. Masatsugu U, Minoru U, Yoshito T, Ken U, Koji K, Hideji F et al. Biological Implications of Growth Factors on the Mechanism of Invasion in Gynecological Tumor Cells. Gynecol Obstet Invest 1999;48:221-8.
5. Karasik A, Menczer L, Pariente C, Kanety H. Insulin-Like Growth Factor-1 (IGF-1) and IGF_Binding Protein-2 Are Increased in Cyst Fluids of Epithelial Ovarian Cancer. J Clin Endosc Met 1994;78(2):271-6.
6. Kanety H, Kattan M, Goldberg I, Kopolovic J, Ravia L, Menczer J et al. Increased insulin-like growth factor binding protein-2 (IGFPB-2) gene expression and protein production lead to high IGFPB-2 content in malignant ovarian cyst fluid. Br J Cancer 1996;73: 1069-73.
7. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS. Elevated serum insulin-like growth factor-binding protein 2 (IGFPB-2) and decreased IGFPB-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 1997;82(7):2308-13.
8. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
9. Stewart CEH, Rotwein P. Growth, differentiation, and survival, multiple physiological functions lor insulin-like growth factors. Physiol Rev 1996;76:1005-6.
10. Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997;18: 801-31.
11. Conover CA. Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J 1996;43:43-8.
12. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR et al. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 1995;377: 646-9.
13. Oh Y, Muller HL, Ng L, Rosenfeld RG. Transforming growth factor-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 1995;270:13589-92.
14. Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor b2-induced inhibition in human breast cancer cells. Cancer Res 1996;50: 1545-50.
15. Colston KW, Perks CM, Xie SP, Holly JM. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J Mol Endocriol 1998;20:157-62.
16. Berns EM, Klijn JG, Henzen-Logmans SC, Rodenburg CJ, van der Burg ME, Foekens JA. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int J Cancer 1992;52: 218-24.
17. Weigang B, Nap M, Bittl A, Jaeger W. Immunohistochemical localization of insulin-like growth factor I receptors in benign and malignant tissues of the female genital tract. Tumour Biol 1994;15:236-46.
18. Karasik A, Menezer J, Pariente C, Kanety H. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in syst fluids of epithelial ovarian cancer. J Clin Endocrinol Metab 1994;78:271-6.
19. Wimalasena J, Meehan D, Dostal R, Foster JS, Cameron M, Smith M. Growth factors interact with estradiol and gonadotropins in the regulation of ovarian cancer cell growth and growth factor receptors. Oncol Res 1993;5: 325-7.
20. Yee D, Morales FR, Hamilton TC, von Hoff DD. Expression of insulin-like growth factor 1, its binding proteins, and its receptor in ovarian cancer. Cancer Res 1991;51:5107-12.
21. Muller M, Dietel M, Turzyriski A, Wiechen K. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor 1 receptor in ovarian cancer cells. Int J Cancer 1998;77: 567-71.
22. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS. Elevated serum insulin-like growth factor-binding protein 2 (IGPBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 1997;82:2308-13.
23. Goldstein S, Moerman EJ, Jones RA, Baxter RC. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medl m of senescent and quiescent human fibroblasts. Proc Natl Acad Sci USA 1991;88:9680-4.
24. Cohen P, Lamson G, Okajima T, Rosenfeld RG. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 1993;7:380-6.
25. Rozen F, Zhang J, Pollak M. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breast cancer is associated with increased insulin-like growth factor binding protein-3 accumulation. Int J Oncol 1998;13: 865-9.
26. Gill ZP, Perks CM, Newcomb PV, Holly JM. Insulin-like growth factor-binding protein (IGPBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J Biol Chem 1997;272: 25602-7.
27. Rechler MM. Growth inhibition by insulin-like growth factor (IGF) binding protein 3 - What's IGF got to do with it? [Editorial] Endocrinology 1997;138:2645-7.
28. Oh Y. IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res Treat 1998;47:283-93.
29. DeMellow JSM, Baxter RC. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 1988;156:199-204.
30. Conover CA. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 1992;130:3191-9.
31. Rajah R, Katz L, Nunn S, Solberg P, Beers T, Cohen P. Insulin-like growth factor binding protein (IGFBP) proteases: functional regulations of cell growth. Prog Growth Factor Res 1995;6:273-84.
32. Lee YC, Rechler MM. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilo-dalton (IGFBP) complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I. Endocrinology 1996;137:2051-8.
33. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV. Figueroa JA, Yee D, Correlation of insulinlike growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 1996;88:601-6.
34. Rocha RL, Hilsenbeck SG, Jackson JG, VanDenberg CL, Weng C, Lee AV et al. Insulinlike growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res 1997;3:103-9.
35. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. Br J Cancer 1996;74:1242-7.
36. Yu H, Levesque MA, Khosravi MJ, Clark GM, Diamandis EP. Insulin-like growth factor binding protein-3 and breast cancer survival. Int J Cancer 1998;79:624-8.
37. Lee AV, Hilsenbeck SG, Yee G. IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat 1998;47:295-302.